Currency in USD
| Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| Low estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| High estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| Year ago EPS | -0.6 | -0.69 | -2.71 | -3.43 |
| Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| No. of analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 650k | 670k | 2.7M | 1.8M |
| Low estimate | 650k | 670k | 2.7M | 1.8M |
| High estimate | 650k | 670k | 2.7M | 1.8M |
| Year ago sales | 606k | 651k | 2.54M | 2.7M |
| Sales growth (year/est) | 7.30% | 2.90% | 6.30% | -33.30% |
| Earnings history | 30/03/2023 | 29/06/2023 | 29/09/2023 | 30/12/2023 |
|---|
| Est. EPS | -1.1 | -1.13 | -1.12 | -0.87 |
| Actual EPS | -0.6 | -0.69 | -0.69 | -0.77 |
| Difference | 0.5 | 0.44 | 0.43 | 0.1 |
| Surprise % | 45.50% | 38.90% | 38.40% | 11.50% |
| EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Current estimate | -0.79 | -0.83 | -3.43 | -0.82 |
| 7 days ago | -0.79 | -0.83 | -3.43 | -0.82 |
| 30 days ago | -0.79 | -0.83 | -3.43 | -0.82 |
| 60 days ago | 0 | 0 | -0.64 | -0.93 |
| 90 days ago | 0 | 0 | -0.64 | -0.93 |
| EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
|---|
| Up last 7 days | N/A | N/A | N/A | N/A |
| Up last 30 days | N/A | N/A | N/A | N/A |
| Down last 7 days | N/A | N/A | N/A | N/A |
| Down last 30 days | N/A | N/A | N/A | N/A |
| Growth estimates | XBIO | Industry | Sector(s) | S&P 500 |
|---|
| Current qtr. | -31.70% | N/A | N/A | N/A |
| Next qtr. | -20.30% | N/A | N/A | N/A |
| Current year | -26.60% | N/A | N/A | N/A |
| Next year | 76.10% | N/A | N/A | N/A |
| Next 5 years (per annum) | N/A | N/A | N/A | N/A |
| Past 5 years (per annum) | N/A | N/A | N/A | N/A |
